India starts enrolling covid-19 patients for test of new drugs

In this study, adults recently hospitalized, or already in hospital, with definite moderate or severe covid-19 would be given infliximab as a single IV infusion or two tablets imatinib once a day for 14 days

from mint - Science https://ift.tt/3zBboYL
https://ift.tt/eA8V8J